Advertisement
Screener

OPTHEA LIMITED (CKDXF) Form 6-K: Report of foreign private issuer, 2023

OPTHEA LIMITED Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-27: Form 6-K; Period of report 2023-12-27; Description 6-K; Document opt_amended_dfa.htm.
  • 2023-12-19: Form 6-K; Period of report 2023-12-19; Description 6-K; Document opt_6-k_rd_tax_2023.htm.
  • 2023-11-30: Form 6-K; Period of report 2023-11-30; Description 6-K; Document opt_6-k_floretina_2023.htm.
  • 2023-11-30: Form 6-K; Period of report 2023-11-30; Description 6-K; Document opt_6-k_chair_address_20.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-276-K2023-12-276-Kopt_amended_dfa.htm
2023-12-196-K2023-12-196-Kopt_6-k_rd_tax_2023.htm
2023-11-306-K2023-11-306-Kopt_6-k_floretina_2023.htm
2023-11-306-K2023-11-306-Kopt_6-k_chair_address_20.htm
2023-11-096-K2023-11-096-Kopt_6-k_jefferies_london.htm
2023-10-306-K2023-10-306-Kopt_6-k_eyecelerator.htm
2023-10-276-K2023-10-276-Kopt_6-k_opthea_nom.htm
2023-10-276-K2023-10-276-Kopt_6-k_senior_managemen.htm
2023-10-026-K2023-10-026-Kopt_6-k_euretina_2023.htm
2023-09-286-K2023-09-286-Kopt_6-k_opthea_annual_re.htm
2023-09-076-K2023-09-076-Kopt_6-k_hc_ww_25th_1.htm
2023-08-316-K2023-08-316-Kd454120d6k.htm
2023-08-286-K2023-08-286-Kd541344d6k.htm
2023-08-246-K2023-08-246-Kd547431d6k.htm
2023-08-016-K2023-08-016-Kopt_6-k_asrs_presentatio.htm
2023-07-266-K2023-07-266-Kopt_6-k_sozinibercept.htm
2023-07-246-K2023-07-246-Kopt_6-k_ois_2023.htm
2023-07-136-K2023-07-136-Kopt_6-k_asrs2023.htm
2023-07-106-K2023-07-106-Kopt_6-k_cmo_resignation.htm
2023-06-086-K2023-06-086-Kopt_6-k_appoints_at.htm
2023-05-256-K2023-05-256-Kopt_6-k_jefferies_2023.htm
2023-05-176-K2023-05-176-Kopt_6-k_ef_hutton.htm
2023-05-086-K2023-05-086-Kopt_6-k_jmpsecurities.htm
2023-04-286-K2023-04-286-Kopt_6-k_hc_wainwright.htm
2023-03-076-K2023-03-076-Kopt_6-k_rd_8.7m.htm
2023-03-066-K2023-03-066-Kopt_6-k_fireside.htm
2023-02-236-K2023-02-236-Kopt_6-k_half_year_result.htm
2023-02-136-K2023-02-136-Kopt_6-k_opthea_ph_2b_res.htm
2023-02-066-K2023-02-066-Kopt_6-k_svb_leerink_conf.htm
2023-01-306-K2023-01-306-Kopt_6-k_sequire_biotechn.htm
2023-01-116-K2023-01-116-Kopt_6-k_corporate_presen.htm